A potential role for protease nexin 1 overexpression in the pathogenesis of scleroderma

Journal of Clinical Investigation

Volumn 103, Issue 8, 1999, Pages 1179-1190

  Strehlow, David ^a   Jelaska, Ante ^a   Strehlow, Karen ^a,c   Korn, Joseph H ^a,b  

^a BOSTON UNIVERSITY MEDICAL CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEASE NEXIN I;

ARTICLE; AUTOIMMUNITY; ENZYME ACTIVE SITE; EXTRACELLULAR MATRIX; FIBROBLAST; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IN SITU HYBRIDIZATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FAMILY; SCLERODERMA; SKIN BIOPSY;

EID: 0033561223     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI1918     Document Type: Article

References (27)

1. Silman, A.J., and Hochberg, M.C. 1993. Epidemiology of the rheumatic diseases. Oxford University Press. New York, NY. 192-199.
2. Mitchell, H., Bolster, M.B., and LeRoy, E.C. 1997. Scleroderma and related conditions. Med. Clin. North. Am. 81:129-149.
3. Kahari, V.M., Sandberg, M., Kalimo, H., Vuorio, T., and Vuorio, E. 1988. Identification of fibroblasts responsible for increased collagen production in localized scleroderma by in situ hybridization. J. Invest. Dermatol. 90:664-670.
4. Claman, H.N., Giorno, R.C., and Seibold, J.R. 1991. Endothelial and fibroblastic activation in scleroderma. The myth of the "uninvolved skin". Arthritis Rheum. 34:1495-1501.
5. Jelaska, A., Arakawa, M., Broketa, G., and Korn, J.H. 1996. Heterogeneity of collagen synthesis in normal and systemic sclerosis skin fibroblasts. Increased proportion of high collagen-producing cells in systemic sclerosis fibroblasts. Arthritis Rheum. 39:1338-1446.
6. Vuorio, T.K., Kahan, V.M., Lehtonen, A., and Vuorio, E.I. 1984. Fibroblast activation in scleroderma. Scand J. Rheumatol. 13:229-237.
7. Baker, J.B., Low, D.A., Simmer, R.L., and Cunningham, D.D. 1980. Protease-nexin: a cellular component that links thrombin and plasminogen activator and mediates their binding to cells. Cell. 21:37-45.
8. Scott, R.W., et al. 1985. Protease nexin. Properties and a modified purification procedure. J. Biol. Chem. 260:7029-7034.
9. LeRoy, E.C., et al. 1988. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J. Rheumatol. 15:202-205.
10. Chomczynski, P. 1993. A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. Biotechniques. 15:532-534, 536-537.
11. Rosen, K.M., Lamperti, E.D., and Villa-Komaroff, L. 1990. Optimizing the Northern blot procedure. Biotecbniques. 8:398-403.
12. Davis, L.G., Dibner, M.D., and Battey, J.F. 1986. Basic methods in molecular biology. Elsevier Science Publishers. New York, NY. 306-314.
13. Liang, P., Averboukh, L., and Pardee, A.B. 1993. Distribution and cloning of eukaryotic mRNAs by means of differential display: refinements and optimization. Nucleic Acids Res. 21:3269-3275.
14. Sassoon, D., and Rosenthal, N. 1993. Detection of messenger RNA by in situ hybridization. Methods Enzymol. 225:384-404.
15. Chu, G., and Berg, P. 1987. Electroporation for the efficient transfection of mammalian cells with DNA. Nucleic Acids Res. 15:1311-1326.
16. Bedalov, A., et al. 1994. Regulation of the alpha 1(1) collagen promoter in vascular smooth muscle cells. Comparison with other alpha 1(I) collagen-producing cells in transgenic animals and cultured cells. J. Biol. Chem. 269:4903-4909.
17. Chauchereau, A., Asrinotti, D., and Bouton, M.M. 1990. Automation of a chloramphenicol acetyltransferase assay. Anal. Biochem. 188:310-316.
18. Nielsen, D.A., Chang, T.C., and Shapiro, D.J. 1989. A highly sensitive, mixed-phase assay for chloramphenicol acetyltransferase activity in transfected cells. Anal. Biochem. 179:19-23.
19. Sommer, J., et al. 1987. cDNA sequence coding for a rat glia-derived nexin and its homology to members of the serpin superfamily. Biochemistry. 26:6407-6410.
20. Farrell, D.H., and Cunningham, D.D. 1986. Human fibroblasts accelerate the inhibition of thrombin by protease nexin. Proc. Natl. Acad. Sci. USA. 83:6858-6862.
21. Liang, P., and Pardee, A.B. 1995. Recent advances in differential display. Curr. Opin. Immunol. 7:274-280.
22. Liang, P., et al. 1995. Analysis of altered gene expression by differential display. Methods Enzymol. 254:304-321.
23. Liang, P., et al. 1994. Differential display using one-base anchored oligodT primers. Nucleic Acids Res. 22:5763-5764.
24. Hitraya, E.G., and Jimenez, S.A. 1996. Transcriptional activation of the alpha 1(I) procollagen gene in systemic sclerosis dermal fibroblasts. Role of intronic sequences. Arthritis Rheum. 39:1347-1354.
25. Howard, E.W., and Knauer, D.J. 1986. Biosynthesis of protease nexin-I. J. Biol. Chem. 261:14184-14190.
26. McGrogan, M., et al. 1990. Structure of the human protease nexin gene and expression of recombinant forms of PN-1. In Serine protease and their serpin inhibitors in the nervous system. B.W. Festoff, editor. Plenum Press. New York, NY. 147-161.
27. Eckes, B., Mauch, C., Huppe, G., and Krieg, T. 1996. Differential regulation of transcription and transcript stability of pro-alpha 1(I) collagen and fibronectin in activated fibroblasts derived from patients with systemic scleroderma. Biochem. J. 315:549-554.